Back
Alkermes PLC Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
48
ALKS
Alkermes PLC
Last Price:
$33.89
Seasonality Move:
2.42%
Buy
52
SRPT
Sarepta Therapeutics
Last Price:
$73.63
Seasonality Move:
14.66%
Sell
48
Alkermes PLC (ALKS)
is a Sell
Is Alkermes PLC a Buy, Sell or Hold?
-
The current Alkermes PLC [ALKS] share price is $34.79. The Score for ALKS is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
ALKS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $76.33. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALKS Stock Price Chart
What is Alkermes PLC's stock price today?
-
The Alkermes PLC share price today is $34.79The current trend is moderately bearish and ALKS is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $76.33Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALKS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.37 | Buy |
| Relative Strength Index (14 RSI): | 56.59 | Buy |
| Chaikin Money Flow: | -1005526 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.99 - 35.45) | Buy |
| Bollinger Bands (100): | (28.1 - 33.5) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -9.07 | Sell |
| Relative Strength Index (14 RSI): | 30.8 | Sell |
| Chaikin Money Flow: | 1304026 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (86.54 - 110.54) | Sell |
| Bollinger Bands (100): | (102.23 - 127.85) | Sell |
ALKS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.25 | Buy |
| 20-day SMA: | 34.44 | Buy |
| 50-day SMA: | 32.65 | Buy |
| 200-day SMA: | 28.62 | Buy |
| 8-day EMA: | 34.39 | Buy |
| 20-day EMA: | 34.19 | Buy |
| 50-day EMA: | 32.99 | Buy |
| 200-day EMA: | 29.75 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 84.29 | Sell |
| 20-day SMA: | 96.26 | Sell |
| 50-day SMA: | 107.61 | Sell |
| 200-day SMA: | 124.92 | Sell |
| 8-day EMA: | 82.75 | Sell |
| 20-day EMA: | 92.99 | Sell |
| 50-day EMA: | 104.03 | Sell |
| 200-day EMA: | 117.97 | Sell |
Alkermes PLC Earnings Growth & ALKS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.16 per share, a decrease this year of $0.77 per share, and a decrease next year of $0.02 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.
Alkermes PLC Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||